Spotlight Therapeutics, a Bay Area biotech company that raised $66 million from investors, including GV, has shut down.
The FDA recently granted EXG-34217 Rare Pediatric Disease Designation (RPDD) and Regenerative Medicine Advanced Therapy (RMAT) Designation.
CAPLYTA net product sales grew to $199.2 million, representing a 51%increase over the same period in 2023Full year 2024 ...
The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...
According to a research report "Global Defense Industry Outlook" The global military expenditure is estimated to be USD 2,563.1 billion in ...
For Lilly, the agreement comes a couple of months after it completed a takeover of German ADC specialist Emergence Therapeutics and its lead candidate ETX-22 – a nectin-4-targeting drug that ...
TheCollector on MSN3d
Post-Modern Stoics? The Revival of Stoicism in the Late 20th CenturyIt probably should not be too much of a surprise that Stoicism, one of the most deviant and uncharacteristic branches of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback